DS Robinson, A Tsicopoulos, Q Meng, S Durham, AB Kay and Q Hamid
National Heart and Lung Institute, London, United Kingdom.

Interleukin-10 (IL-10) inhibits T-lymphocyte proliferation and production of cytokines. We have examined expression of IL-10 messenger RNA (mRNA) in atopic asthma and in allergen and tuberculin skin responses by in situ hybridization. The proportion of bronchoalveolar lavage (BAL) cells positive for IL-10 mRNA was increased in a group of 10 symptomatic asthmatics when compared with control subjects (17.5% versus 5.2% BAL cells positive; P < 0.001). In a separate group of six mild atopic asthmatics, there was an increased proportion of BAL cells positive for IL-10 mRNA 24 h after allergen inhalation challenge compared with diluent challenge BAL from the same subjects (24% versus 10%; P < 0.005). By simultaneous in situ hybridization and immunocytochemistry, IL-10 mRNA was localized to both CD3+ T cells and CD68+ alveolar macrophages in BAL, with a significantly more prominent T-cell signal in the symptomatic asthmatics compared with control subjects and after allergen challenge compared with diluent challenge of the mild asthmatic subjects. It has been suggested that IL-10 production is a late event after T-cell activation. To examine kinetics and specificity of IL-10 mRNA expression, skin biopsies were obtained from atopic, tuberculin-sensitive subjects at 1, 6, and 48 h after cutaneous injection of allergen or tuberculin. With both stimuli, there was an increase in IL-10 mRNA-positive cells at 6 h when compared with control sites injected with appropriate diluent which were biopsied 24 h after injection (P < 0.01 for allergen and P < 0.02 for tuberculin). These findings are compatible with the hypothesis that IL-10 mRNA is expressed in both macrophages and T lymphocytes in the airway in asthma and that IL-10 mRNA expression is induced from T lymphocytes in response to allergen. This response may also occur in other types of cell-mediated inflammation.

This article has been cited by other articles:

				K.-a. Moon, S. Y. Kim, T.-B. Kim, E. S. Yun, C.-S. Park, Y. S. Cho, H.-B. Moon, and K.-Y. Lee Allergen-induced CD11b+ CD11cint CCR3+ macrophages in the lung promote eosinophilic airway inflammation in a mouse asthma model Int. Immunol., December 1, 2007; 19(12): 1371 - 1381. [Abstract] [Full Text] [PDF]

				E. Lopez, V. del Pozo, T. Miguel, B. Sastre, C. Seoane, E. Civantos, E. Llanes, M. L. Baeza, P. Palomino, B. Cardaba, et al. Inhibition of Chronic Airway Inflammation and Remodeling by Galectin-3 Gene Therapy in a Murine Model J. Immunol., February 1, 2006; 176(3): 1943 - 1950. [Abstract] [Full Text] [PDF]

				C. C. Dong, X. J. Yin, J. Y. C. Ma, L. Millecchia, M. W. Barger, J. R. Roberts, X.-D. Zhang, J. M. Antonini, and J. K. H. Ma Exposure of Brown Norway Rats to Diesel Exhaust Particles Prior to Ovalbumin (OVA) Sensitization Elicits IgE Adjuvant Activity but Attenuates OVA-Induced Airway Inflammation Toxicol. Sci., November 1, 2005; 88(1): 150 - 160. [Abstract] [Full Text] [PDF]

				L. Pitzurra, S. Bellocchio, A. Nocentini, P. Bonifazi, R. Scardazza, L. Gallucci, F. Stracci, C. Simoncelli, F. Bistoni, and L. Romani Antifungal Immune Reactivity in Nasal Polyposis Infect. Immun., December 1, 2004; 72(12): 7275 - 7281. [Abstract] [Full Text] [PDF]

				J. W. Steinke, E. Barekzi, J. Hagman, and L. Borish Functional Analysis of -571 IL-10 Promoter Polymorphism Reveals a Repressor Element Controlled by Sp1 J. Immunol., September 1, 2004; 173(5): 3215 - 3222. [Abstract] [Full Text] [PDF]

				K. Hashimoto, B. S. Graham, S. B. Ho, K. B. Adler, R. D. Collins, S. J. Olson, W. Zhou, T. Suzutani, P. W. Jones, K. Goleniewska, et al. Respiratory Syncytial Virus in Allergic Lung Inflammation Increases Muc5ac and Gob-5 Am. J. Respir. Crit. Care Med., August 1, 2004; 170(3): 306 - 312. [Abstract] [Full Text] [PDF]

				A. J. Reefer, R. M. Carneiro, N. J. Custis, T. A. E. Platts-Mills, S.-S. J. Sung, J. Hammer, and J. A. Woodfolk A Role for IL-10-Mediated HLA-DR7-Restricted T Cell-Dependent Events in Development of the Modified Th2 Response to Cat Allergen J. Immunol., March 1, 2004; 172(5): 2763 - 2772. [Abstract] [Full Text] [PDF]

				J.-F. Bach The Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases N. Engl. J. Med., September 19, 2002; 347(12): 911 - 920. [Full Text] [PDF]

				C. G. Lee, R. J. Homer, L. Cohn, H. Link, S. Jung, J. E. Craft, B. S. Graham, T. R. Johnson, and J. A. Elias Transgenic Overexpression of Interleukin (IL)-10 in the Lung Causes Mucus Metaplasia, Tissue Inflammation, and Airway Remodeling via IL-13-dependent and -independent Pathways J. Biol. Chem., September 13, 2002; 277(38): 35466 - 35474. [Abstract] [Full Text] [PDF]

				N G Papadopoulos, L A Stanciu, A Papi, S T Holgate, and S L Johnston A defective type 1 response to rhinovirus in atopic asthma Thorax, April 1, 2002; 57(4): 328 - 332. [Abstract] [Full Text] [PDF]

				M. M. Grunstein, H. Hakonarson, J. Leiter, M. Chen, R. Whelan, J. S. Grunstein, and S. Chuang Autocrine signaling by IL-10 mediates altered responsiveness of atopic sensitized airway smooth muscle Am J Physiol Lung Cell Mol Physiol, November 1, 2001; 281(5): L1130 - L1137. [Abstract] [Full Text] [PDF]

				J.C. Kips Cytokines in asthma Eur. Respir. J., July 2, 2001; 18(34_suppl): 24S - 33s. [Abstract] [Full Text] [PDF]

				D. A. Knight, P. G. Holt, and P. D. Sly Lipopolysaccharide Inhibits the Late-Phase Response to Allergen by Altering Nitric Oxide Synthase Activity and Interleukin-10 Am. J. Respir. Cell Mol. Biol., May 1, 2001; 24(5): 640 - 646. [Abstract] [Full Text]

				S. LIM, N. ROCHE, B. G. OLIVER, W. MATTOS, P. J. BARNES, and K. FAN CHUNG Balance of Matrix Metalloprotease-9 and Tissue Inhibitor of Metalloprotease-1 from Alveolar Macrophages in Cigarette Smokers . Regulation by Interleukin-10 Am. J. Respir. Crit. Care Med., October 1, 2000; 162(4): 1355 - 1360. [Abstract] [Full Text] [PDF]

				P. K. Jeffery Comparison of the Structural and Inflammatory Features of COPD and Asthma Giles F. Filley Lecture Chest, May 1, 2000; 117(5_suppl_1): 251S - 260S. [Abstract] [Full Text] [PDF]

				M. R. van Scott, J. P. Justice, J. F. Bradfield, E. Enright, A. Sigounas, and S. Sur IL-10 reduces Th2 cytokine production and eosinophilia but augments airway reactivity in allergic mice Am J Physiol Lung Cell Mol Physiol, April 1, 2000; 278(4): L667 - L674. [Abstract] [Full Text] [PDF]

				K F Chung and P J Barnes Cytokines in asthma Thorax, September 1, 1999; 54(9): 825 - 857. [Full Text]

				S. S. Tinkle, L. A. Kittle, and L. S. Newman Partial IL-10 Inhibition of the Cell-Mediated Immune Response in Chronic Beryllium Disease J. Immunol., September 1, 1999; 163(5): 2747 - 2753. [Abstract] [Full Text] [PDF]

				J. T. Wise, T. J. Baginski, and J. L. Mobley An Adoptive Transfer Model of Allergic Lung Inflammation in Mice Is Mediated by CD4+CD62LlowCD25+ T Cells J. Immunol., May 1, 1999; 162(9): 5592 - 5600. [Abstract] [Full Text] [PDF]

				P. J. Barnes, K. F. Chung, and C. P. Page Inflammatory Mediators of Asthma: An Update Pharmacol. Rev., December 1, 1998; 50(4): 515 - 596. [Abstract] [Full Text] [PDF]

				E. A. B. KELLY, R. R. RODRIGUEZ, W. W. BUSSE, and N. N. JARJOUR The Effect of Segmental Bronchoprovocation with Allergen on Airway Lymphocyte Function Am. J. Respir. Crit. Care Med., November 1, 1997; 156(5): 1421 - 1428. [Abstract] [Full Text]

				G. Grunig, D. B. Corry, M. W. Leach, B. W.P. Seymour, V. P. Kurup, and D. M. Rennick Interleukin-10 Is a Natural Suppressor of Cytokine Production and Inflammation in a Murine Model of Allergic Bronchopulmonary Aspergillosis J. Exp. Med., March 17, 1997; 185(6): 1089 - 1100. [Abstract] [Full Text] [PDF]

				M. J. Makela, A. Kanehiro, L. Borish, A. Dakhama, J. Loader, A. Joetham, Z. Xing, M. Jordana, G. L. Larsen, and E. W. Gelfand IL-10 is necessary for the expression of airway hyperresponsiveness but not pulmonary inflammation after allergic sensitization PNAS, May 23, 2000; 97(11): 6007 - 6012. [Abstract] [Full Text] [PDF]